International Centre For Genetic Engineering And Biotechnology
Doing business as Icgeb
- UEI
- R77WDJ8AW9A1
- CAGE
- AG022
- Primary NAICS
- Not on record
- SAM.gov registration
- Expired
Company facts
- Self-certified in SAM.gov
- Entity structure
- International Organization
- SAM.gov registration date
- Website
- icgeb.org
- Founded
- 1983
- Employees
- 251-1K
- Estimated annual revenue
- $50M-$100M
- Industry
-
- Health Care
- Pharmaceuticals, Biotechnology & Life Sciences
- Biotechnology
- SIC code
- 87 Engineering & Management Services
Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .
Grant subawards
| Prime recipient | Prime award | Amount | Awarded |
|---|---|---|---|
| The Washington University | R01AI143857 | $0 | |
| The Washington University | R01AI143857 | $5,400 | |
| The Washington University | R01AI143857 | $48,600 |
Similar vendors
| Vendor | Location | Primary NAICS |
|---|---|---|
| Fundacion Instituto De Investigaciones Biotecnologicas | Villa Lynch, CABA | 541714 Research and Development in Biotechnology (except Nanobiotechnology) |
| A*Star Infectious Diseases Labs | Singapore | — |
| C-Camp | KA | — |
| Hauptman Woodward Medical Research Institute, Inc. | — | 541714 Research and Development in Biotechnology (except Nanobiotechnology) |
| Chubu University | Kasugai, Aichi | — |
About the company
International Centre For Genetic Engineering And Biotechnology, doing business as Icgeb, is an international organization registered as a non-profit entity with the U.S. federal government since December 15, 2006. As a recipient of federal grant sub-awards, Icgeb specializes in genetic engineering and biotechnology research. The organization's expertise lies in structural biology, enzymology, and biochemical studies, particularly focusing on tRNA synthases and their inhibitors. Icgeb collaborates with other research institutions and universities to advance scientific knowledge in areas such as infectious diseases and drug development.
Icgeb has been involved in a significant research project aimed at identifying small molecule inhibitors to cure chronic toxoplasmosis. This work is conducted under a federal grant sub-award from The Washington University, with the project identifier R01AI143857. Dr. Amit Sharma, a co-investigator at Icgeb's Delhi, India facility, leads the biochemical studies on bicyclic azetidine inhibitors. The research involves testing existing and new compounds for inhibition of TG PheRS enzyme in vitro, as well as evaluating top active compounds on mutant TgPheRS, human PheRS, and P. falciparum PheRS. This project showcases Icgeb's capabilities in enzyme inhibition studies, structural biology, and drug discovery, particularly in the context of parasitic diseases. The organization's involvement in this grant demonstrates its role in supporting U.S. federal research initiatives in global health and biotechnology.
Quick answers
Is International Centre For Genetic Engineering And Biotechnology registered in SAM.gov?
International Centre For Genetic Engineering And Biotechnology's SAM.gov registration expired on March 30, 2024.
On GovTribe
See International Centre For Genetic Engineering And Biotechnology's full federal record
- Similar vendors